LivaNova PLC
NASDAQ:LIVN
LivaNova PLC
NASDAQ:LIVN
Price:
62.92 USD
0.48%
Market Closed
Updated:
May 3, 2024
P/S
Price to Sales
Price to Sales
2.9
Current
2.9
Median
2.4
Industry
Higher
than median
Higher
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=2.9
Market Cap
/
3.4B
Revenue
1.2B
All Countries
| Market Cap | P/S | ||||
|---|---|---|---|---|---|
| UK |
|
LivaNova PLC
NASDAQ:LIVN
|
3.4B USD | 2.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.7B USD | 4.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
134B USD | 18.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
124.3B USD | 5.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.6B USD | 3.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
105.6B USD | 7.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
69.4B USD | 3.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.1B EUR | 2.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.2B USD | 8.3 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.2B USD | 13.2 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
2.8
2-Years Forward
P/S
2.6
3-Years Forward
P/S
2.5
You don't have any saved screeners yet
